FDA Approves First Biologic Treatment for Polymyalgia Rheumatica ...Middle East

Medscape - News
The interleukin-6 receptor antagonist sarilumab (Kevzara) will be indicated in adults who have had an inadequate response to corticosteroids or could not tolerate a corticosteroid taper. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Biologic Treatment for Polymyalgia Rheumatica )

Also on site :